Dopaminergic Control of Inflammation and Glycemia in Sepsis and Diabetes
Most preclinical treatments for sepsis failed in clinical trials in part because the experimental models of sepsis were performed on healthy animals that do not mimic septic patients. Here, we report that experimental diabetes worsens glycemia, inflammation, and mortality in experimental sepsis. Dia...
Main Authors: | Eleonora Feketeova, Zhifeng Li, Biju Joseph, Roshan Shah, Zoltan Spolarics, Luis Ulloa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00943/full |
Similar Items
-
Marcadores humorales en la sepsis severa Humoral markers in severe sepsis
by: Alfredo Sánchez Valdivia, et al.
Published: (2006-12-01) -
Multi-Organ Transcriptome Dynamics in a Mouse Model of Cecal Ligation and Puncture-Induced Polymicrobial Sepsis
by: Rumienczyk I, et al.
Published: (2021-06-01) -
The effects of long-term dopaminergic treatment on locomotor behavior in rats
by: Welinton Alessandro Oliveira de Almeida, et al.
Published: (2014-12-01) -
Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist
by: Anastasia P Athanasoulia-Kaspar, et al.
Published: (2018-02-01) -
Sepsis: la otra cara de la respuesta inmune = Sepsis: the other face of immune response
by: Zapata Ospina, Juan Pablo
Published: (2011-06-01)